geriatrРоссийский журнал гериатрической медициныRussian Journal of Geriatric Medicine2686-86362686-8709Сайт издателя10.37586/2686-8636-4-2022-236-249geriatr-306Research ArticleОБЗОРЫREVIEWSВитамин К и возраст-ассоциированные заболеванияVitamin K and age-related diseaseshttps://orcid.org/0000-0003-0048-268XЕруслановаК. А.EruslanovaK. A.

Ерусланова Ксения Алексеевна - кандидат медицинских наук, заведующая лабораторией сердечно-сосудистого старения.

Москва, телефон: +7(499)187-78-09

Eruslanova Ksenia A. - MD, PhD, Head of Laboratory of Cardiovascular Aging.

Moscow +7(499)187-78-09

Eruslanova_KA@rgnkc.ruhttps://orcid.org/0000-0002-0556-1697ОнучинаЮ. С.OnuchinaYu. S.

Онучина Юлия Сергеевна - кандидат медицинских наук, научный сотрудник лаборатории возрастных метаболических и эндокринных нарушений.

Москва, телефон: +7(985)436-69-31

Onuchina Yulia S. - MD, PhD, research fellow, Age-related Endocrine and Metabolic Disorders Laboratory.Moscow +7(985)436-69-31

onuchina90@list.ruhttps://orcid.org/0000-0002-2764-1049ИванниковаЕ. В.IvannikovaE. V.

Иванникова Екатерина Владимировна - кандидат медицинских наук, старший научный сотрудник лаборатории возрастных метаболических и эндокринных нарушений, Scopus: 55342021000.

Москва

Izyumov Andrey D. - MD, geriatrician.

Moscow

doc.ivannikova@gmail.comhttps://orcid.org/0000-0001-7891-6850ДудинскаяЕ. Н.DudinskayaE. N.

Дудинская Екатерина Наильевна - доктор медицинских наук, заведующая лабораторией возрастных метаболических и эндокринных нарушений.

Москва, телефон: +7(903)191-46-90

Dudinskaya Ekaterina N. - MD, PhD, professor, Head of Age-related Endocrine and Metabolic Disorders Laboratory, Russian Gerontology Research and Clinical Centre.

Moscow +7(903)191-46-90

katharina.gin@gmail.comФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России, Российский геронтологический научно-клинический центрРоссияPirogov National Research Medical University, Russian Gerontology Research and Clinical CentreRussian Federation20220102202304236249Copyright © Ерусланова К.А., Онучина Ю.С., Иванникова Е.В., Дудинская Е.Н., 20232023Ерусланова К.А., Онучина Ю.С., Иванникова Е.В., Дудинская Е.Н.Eruslanova K.A., Onuchina Y.S., Ivannikova E.V., Dudinskaya E.N.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.geriatr-news.com/jour/article/view/306

Витамин К относится к жирорастворимым витаминам, и его роль в обмене веществ, работе костной и соединительной тканей, а также свертывающей системе крови хорошо известна. Цель этого обзора — рассказать об участии двух витамеров витамина К — витамина К1 (филлохинон) и витамина К2 (менахиноны) — в патогенезе возраст-ассоциированных заболеваний.

Vitamin K is a fat-soluble vitamin and its role in metabolism, bone and connective tissue, and blood coagulation is well known. The purpose of this review is to identify and detail the involvement of two vitamin K vitamers, K1 or phylloquinone, and vitamin K2 or menaquinone, in the pathogenesis of age-related diseases.

питаниевозраст-ассоциированные заболеваниявитамин Кишемическая болезнь сердцасосудистая кальцификацияантикоагулянтыпаденияnutritionage-associated diseasesvitamin Kcardiac ischemiavascular calcificationanticoagulantsfallReferencesDam H., Schønheyder F. The occurrence and chemical nature of vitamin K. Biochem. J. 1936;30:897–901. DOI: 10.1042/bj0300897.Dam H., Schønheyder F. The occurrence and chemical nature of vitamin K. Biochem. J. 1936;30:897–901. DOI: 10.1042/bj0300897.Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb. Haemost. 2017;100:530–547.Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb. Haemost. 2017;100:530–547.Rishavy M.A., Berkner K.L. Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv Nutr. 2012 Mar 1;3(2):135–48. DOI: 10.3945/an.111.001719. PMID: 22516721; PMCID: PMC3648714.Rishavy M.A., Berkner K.L. Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv Nutr. 2012 Mar 1;3(2):135–48. DOI: 10.3945/an.111.001719. PMID: 22516721; PMCID: PMC3648714.Kuwabara A., Uenishi K., Tanaka K. Vitamin K intake and health, consideration from the epidemiological studies. J Clin Biochem Nutr. 2021 Sep;69(2):111–121. DOI: 10.3164/jcbn.20-64. Epub 2021 Mar 25. PMID: 34616102; PMCID: PMC8482381.Kuwabara A., Uenishi K., Tanaka K. Vitamin K intake and health, consideration from the epidemiological studies. J Clin Biochem Nutr. 2021 Sep;69(2):111–121. DOI: 10.3164/jcbn.20-64. Epub 2021 Mar 25. PMID: 34616102; PMCID: PMC8482381.Booth S.L. Vitamin K: Food composition and dietary intakes. Food Nutr. Res. 2017;56:5505. DOI: 10.3402/fnr.v56i0.5505.Booth S.L. Vitamin K: Food composition and dietary intakes. Food Nutr. Res. 2017;56:5505. DOI: 10.3402/fnr.v56i0.5505.Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb. Haemost. 2017;100:530–547.Shearer M.J., Newman P. Metabolism and cell biology of vitamin K. Thromb. Haemost. 2017;100:530–547.Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.U.S. Department of Agriculture, Agricultural Research Service. FoodData Centralexternal link disclaimer, 2019.U.S. Department of Agriculture, Agricultural Research Service. FoodData Centralexternal link disclaimer, 2019.Tarento T.D.C., McClure D.D., Talbot A.M., Regtop H.L., Biffin J.R., Valtchev P., Dehghani F., Kavanagh J.M. A potential biotechnological process for the sustainable production of vitamin K 1. Crit. Rev. Biotechnol. 2018;69:1–19. DOI: 10.1080/07388551.2018.1474168.Tarento T.D.C., McClure D.D., Talbot A.M., Regtop H.L., Biffin J.R., Valtchev P., Dehghani F., Kavanagh J.M. A potential biotechnological process for the sustainable production of vitamin K 1. Crit. Rev. Biotechnol. 2018;69:1–19. DOI: 10.1080/07388551.2018.1474168.Marles R.J., Roe A.L., Oketch-Rabah H.A. US Pharmacopeial Convention safety evaluation of menaquinone-7, a form of vitamin K. Nutr. Rev. 2017;75:553–578. DOI: 10.1093/nutrit/nux022Marles R.J., Roe A.L., Oketch-Rabah H.A. US Pharmacopeial Convention safety evaluation of menaquinone-7, a form of vitamin K. Nutr. Rev. 2017;75:553–578. DOI: 10.1093/nutrit/nux022Akbulut A.C., Pavlic A., Petsophonsakul P., Halder M., Maresz K., Kramann R., Schurgers L. Vitamin K2 Needs an RDI Separate from Vitamin K1. Nutrients. 2020 Jun 21;12(6):1852. DOI: 10.3390/nu12061852. PMID: 32575901; PMCID: PMC7353270.Akbulut A.C., Pavlic A., Petsophonsakul P., Halder M., Maresz K., Kramann R., Schurgers L. Vitamin K2 Needs an RDI Separate from Vitamin K1. Nutrients. 2020 Jun 21;12(6):1852. DOI: 10.3390/nu12061852. PMID: 32575901; PMCID: PMC7353270.Vermeer C., Raes J., van t Hoofd C., Knapen M., Xanthoulea S. Menaquinone Content of Cheese. Nutrients. 2018;10:446. DOI: 10.3390/nu10040446.Vermeer C., Raes J., van t Hoofd C., Knapen M., Xanthoulea S. Menaquinone Content of Cheese. Nutrients. 2018;10:446. DOI: 10.3390/nu10040446.Sánchez-Fuentes A., Rivera-Caravaca J.M., López-Gálvez R., Marín F., Roldán V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 2022 Jan 17;8:787235. DOI: 10.3389/fcvm.2021.787235. PMID: 35111826; PMCID: PMC8801490.Sánchez-Fuentes A., Rivera-Caravaca J.M., López-Gálvez R., Marín F., Roldán V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 2022 Jan 17;8:787235. DOI: 10.3389/fcvm.2021.787235. PMID: 35111826; PMCID: PMC8801490.Fusaro M., Mereu M.C., Aghi A., Iervasi G.G.M. Vitamin K and bone. Clinical Cases in Mineral and Bone Metabolism. 2017;14(2):200–206. DOI: 10.11138/ccmbm/2017.14.1.200.Fusaro M., Mereu M.C., Aghi A., Iervasi G.G.M. Vitamin K and bone. Clinical Cases in Mineral and Bone Metabolism. 2017;14(2):200–206. DOI: 10.11138/ccmbm/2017.14.1.200.Myneni V., Mezey E. Regulation of bone remodeling by vitamin K2. Oral Diseases. 2017;23(8):1021–1028. DOI: 10.1111/odi.12624.Myneni V., Mezey E. Regulation of bone remodeling by vitamin K2. Oral Diseases. 2017;23(8):1021–1028. DOI: 10.1111/odi.12624.Akbari S., Rasouli-Ghahroudi A.A. Vitamin K and bone metabolism: a review of the latest evidence in preclinical studies. BioMed Research International. 2018;2018:8. DOI: 10.1155/2018/4629383.4629383Akbari S., Rasouli-Ghahroudi A.A. Vitamin K and bone metabolism: a review of the latest evidence in preclinical studies. BioMed Research International. 2018;2018:8. DOI: 10.1155/2018/4629383.4629383Halder M., Petsophonsakul P., Akbulut A.C., Pavlic A., Bohan F., Anderson E., Maresz K., Kramann R., Schurgers L. Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease. Int J Mol Sci. 2019 Feb 19;20(4):896. DOI: 10.3390/ijms20040896. PMID: 30791399; PMCID: PMC6413124.Halder M., Petsophonsakul P., Akbulut A.C., Pavlic A., Bohan F., Anderson E., Maresz K., Kramann R., Schurgers L. Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease. Int J Mol Sci. 2019 Feb 19;20(4):896. DOI: 10.3390/ijms20040896. PMID: 30791399; PMCID: PMC6413124.Tie J., Stafford D. Structural and functional insights into enzymes of the vitamin K cycle. J. Thromb. Haemost. 2016;14:236– 247. DOI: 10.1111/jth.13217.Tie J., Stafford D. Structural and functional insights into enzymes of the vitamin K cycle. J. Thromb. Haemost. 2016;14:236– 247. DOI: 10.1111/jth.13217.Park D., Kim D.Y., Byun M.R., Hwang H., Ko S.H., Baek J.H., Baek K. Undercarboxylated, But Not Carboxylated, Osteocalcin Suppresses TNF-α-Induced Inflammatory Signaling Pathway in Myoblasts. J Endocr Soc. 2022 May 29;6(8):bvac084. DOI: 10.1210/jendso/bvac084. PMID: 35702666; PMCID: PMC9188654.Park D., Kim D.Y., Byun M.R., Hwang H., Ko S.H., Baek J.H., Baek K. Undercarboxylated, But Not Carboxylated, Osteocalcin Suppresses TNF-α-Induced Inflammatory Signaling Pathway in Myoblasts. J Endocr Soc. 2022 May 29;6(8):bvac084. DOI: 10.1210/jendso/bvac084. PMID: 35702666; PMCID: PMC9188654.Berkner K.L., Runge K.W. Vitamin K-Dependent Protein Activation: Normal Gamma-Glutamyl Carboxylation and Disruption in Disease. Int J Mol Sci. 2022 May 20;23(10):5759. DOI: 10.3390/ijms23105759. PMID: 35628569; PMCID: PMC9146348.Berkner K.L., Runge K.W. Vitamin K-Dependent Protein Activation: Normal Gamma-Glutamyl Carboxylation and Disruption in Disease. Int J Mol Sci. 2022 May 20;23(10):5759. DOI: 10.3390/ijms23105759. PMID: 35628569; PMCID: PMC9146348.Chatron N., Hammed A., Benoît E., Lattard V. Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1. Nutrients. 2019 Jan 1;11(1):67. DOI: 10.3390/nu11010067. PMID: 30609653; PMCID: PMC6357001.Chatron N., Hammed A., Benoît E., Lattard V. Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1. Nutrients. 2019 Jan 1;11(1):67. DOI: 10.3390/nu11010067. PMID: 30609653; PMCID: PMC6357001.Rishavy M.A., Berkner K.L. Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv Nutr. 2012 Mar 1;3(2):135–48. DOI: 10.3945/an.111.001719. PMID: 22516721; PMCID: PMC3648714.Rishavy M.A., Berkner K.L. Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K-dependent carboxylase. Adv Nutr. 2012 Mar 1;3(2):135–48. DOI: 10.3945/an.111.001719. PMID: 22516721; PMCID: PMC3648714.Fujii S., Shimizu A., Takeda N., Oguchi K., Katsurai T. Systematic synthesis and anti-inflammatory activity of x-carboxylated menaquinone derivatives. Investigations on identified and putative vitamin K2 metabolites. Bioorg. Med. Chem. 2015;23:2344–2352. DOI: 10.1016/j.bmc.2015.03.070.Fujii S., Shimizu A., Takeda N., Oguchi K., Katsurai T. Systematic synthesis and anti-inflammatory activity of x-carboxylated menaquinone derivatives. Investigations on identified and putative vitamin K2 metabolites. Bioorg. Med. Chem. 2015;23:2344–2352. DOI: 10.1016/j.bmc.2015.03.070.Mangge H., Prueller F., Dawczynski C., Curcic P., Sloup Z., Holter M., Herrmann M., Meinitzer A. Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants (Basel). 2022 Jun 24;11(7):1235. DOI: 10.3390/antiox11071235. PMID: 35883726; PMCID: PMC9312339.Mangge H., Prueller F., Dawczynski C., Curcic P., Sloup Z., Holter M., Herrmann M., Meinitzer A. Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants (Basel). 2022 Jun 24;11(7):1235. DOI: 10.3390/antiox11071235. PMID: 35883726; PMCID: PMC9312339.Aksoy A., Al Zaidi M., Repges E., Becher M.U., Müller C., Oldenburg J., Zimmer S., Nickenig G., Tiyerili V. Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype. Front Cardiovasc Med. 2021 Oct 27;8:708946. DOI: 10.3389/fcvm.2021.708946. PMID: 34778390; PMCID: PMC8578699.Aksoy A., Al Zaidi M., Repges E., Becher M.U., Müller C., Oldenburg J., Zimmer S., Nickenig G., Tiyerili V. Vitamin K Epoxide Reductase Complex Subunit 1-Like 1 (VKORC1L1) Inhibition Induces a Proliferative and Pro-inflammatory Vascular Smooth Muscle Cell Phenotype. Front Cardiovasc Med. 2021 Oct 27;8:708946. DOI: 10.3389/fcvm.2021.708946. PMID: 34778390; PMCID: PMC8578699.Emekli-Alturfan E., Alturfan A.A. The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence. Mol Biol Rep. 2022 Nov 3. DOI: 10.1007/s11033-022-07925-w. Epub ahead of print. PMID: 36329336.Emekli-Alturfan E., Alturfan A.A. The emerging relationship between vitamin K and neurodegenerative diseases: a review of current evidence. Mol Biol Rep. 2022 Nov 3. DOI: 10.1007/s11033-022-07925-w. Epub ahead of print. PMID: 36329336.Ambrożewicz E., Muszyńska M., Tokajuk G., Grynkiewicz G., Žarković N., Skrzydlewska E. Beneficial Effects of Vitamins K and D3 on Redox Balance of Human Osteoblasts Cultured with Hydroxypatite-Based Biomaterials. Cells. 2019;8:325. DOI: 10.3390/cells8040325.Ambrożewicz E., Muszyńska M., Tokajuk G., Grynkiewicz G., Žarković N., Skrzydlewska E. Beneficial Effects of Vitamins K and D3 on Redox Balance of Human Osteoblasts Cultured with Hydroxypatite-Based Biomaterials. Cells. 2019;8:325. DOI: 10.3390/cells8040325.Stefaniak O., Dobrzyńska M., Drzymała-Czyż S., Przysławski J. Diet in the Prevention of Alzheimer's Disease: Current Knowledge and Future Research Requirements. Nutrients. 2022 Oct 30;14(21):4564. DOI: 10.3390/nu14214564. PMID: 36364826; PMCID: PMC9656789.Stefaniak O., Dobrzyńska M., Drzymała-Czyż S., Przysławski J. Diet in the Prevention of Alzheimer's Disease: Current Knowledge and Future Research Requirements. Nutrients. 2022 Oct 30;14(21):4564. DOI: 10.3390/nu14214564. PMID: 36364826; PMCID: PMC9656789.Li S., Kim H.E. Implications of Sphingolipids on Aging and Age-Related Diseases. Front Aging. 2022 Mar 3;2:797320. DOI: 10.3389/fragi.2021.797320. PMID: 35822041; PMCID: PMC9261390.Li S., Kim H.E. Implications of Sphingolipids on Aging and Age-Related Diseases. Front Aging. 2022 Mar 3;2:797320. DOI: 10.3389/fragi.2021.797320. PMID: 35822041; PMCID: PMC9261390.Lev M., Milford A. The 3-Ketodihydrosphingosine melaninogenicus: Synthetase of Bacteroides melaninogenicus: Induction by Vitamin K. Arch. Biochem. Biophys. 1973;157:500– 508. DOI: 10.1016/0003-9861(73)90668-1.Lev M., Milford A. The 3-Ketodihydrosphingosine melaninogenicus: Synthetase of Bacteroides melaninogenicus: Induction by Vitamin K. Arch. Biochem. Biophys. 1973;157:500– 508. DOI: 10.1016/0003-9861(73)90668-1.Sundaram K.S., Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J. Lipid Res. 1988;29:1475–1479.Sundaram K.S., Lev M. Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain. J. Lipid Res. 1988;29:1475–1479.Booth S.L., Shea M.K., Barger K., Leurgans S.E., James B.D., Holland T.M., Agarwal P., Fu X., Wang J., Matuszek G., Schneider J.A. Association of vitamin K with cognitive decline and neuropathology in community-dwelling older persons. Alzheimers Dement (N Y). 2022 Apr 20;8(1):e12255. DOI: 10.1002/trc2.12255. PMID: 35475263; PMCID: PMC9019903.Booth S.L., Shea M.K., Barger K., Leurgans S.E., James B.D., Holland T.M., Agarwal P., Fu X., Wang J., Matuszek G., Schneider J.A. Association of vitamin K with cognitive decline and neuropathology in community-dwelling older persons. Alzheimers Dement (N Y). 2022 Apr 20;8(1):e12255. DOI: 10.1002/trc2.12255. PMID: 35475263; PMCID: PMC9019903.Sundaram K.S., Engelke J.A., Foley A.L., Suttie J., Lev M. Vitamin K Status Influences Brain Sulfatide Metabolism in Young Mice and Rats. J. Nutr. 1996;126:2746–2751Sundaram K.S., Engelke J.A., Foley A.L., Suttie J., Lev M. Vitamin K Status Influences Brain Sulfatide Metabolism in Young Mice and Rats. J. Nutr. 1996;126:2746–2751Chen X., Furukawa N., Jin D.Y., Liu Y., Stafford D.W., Williams C.M., Suhara Y., Tie J.K. Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation. FEBS J. 2022 May;289(9):2613–2627. DOI: 10.1111/febs.16291. Epub 2021 Dec 1. PMID: 34813684; PMCID: PMC9064899.Chen X., Furukawa N., Jin D.Y., Liu Y., Stafford D.W., Williams C.M., Suhara Y., Tie J.K. Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation. FEBS J. 2022 May;289(9):2613–2627. DOI: 10.1111/febs.16291. Epub 2021 Dec 1. PMID: 34813684; PMCID: PMC9064899.Ding H., Reiss A.B., Pinkhasov A., Kasselman L.J. Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias. Medicina (Kaunas). 2022 Jul 30;58(8):1025. DOI: 10.3390/medicina58081025. PMID: 36013492; PMCID: PMC9414574.Ding H., Reiss A.B., Pinkhasov A., Kasselman L.J. Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias. Medicina (Kaunas). 2022 Jul 30;58(8):1025. DOI: 10.3390/medicina58081025. PMID: 36013492; PMCID: PMC9414574.Xv F., Chen J., Duan L., Li S. Research progress on the anticancer effects of vitamin K2. Oncol Lett. 2018 Jun;15(6):89268934. DOI: 10.3892/ol.2018.8502. Epub 2018 Apr 16. PMID: 29805627; PMCID: PMC5958717.Xv F., Chen J., Duan L., Li S. Research progress on the anticancer effects of vitamin K2. Oncol Lett. 2018 Jun;15(6):89268934. DOI: 10.3892/ol.2018.8502. Epub 2018 Apr 16. PMID: 29805627; PMCID: PMC5958717.Markowska A., Antoszczak M., Markowska J., Huczyński A. Role of Vitamin K in Selected Malignant Neoplasms in Women. Nutrients. 2022 Aug 18;14(16):3401. DOI: 10.3390/nu14163401. PMID: 36014904; PMCID: PMC9413298.Markowska A., Antoszczak M., Markowska J., Huczyński A. Role of Vitamin K in Selected Malignant Neoplasms in Women. Nutrients. 2022 Aug 18;14(16):3401. DOI: 10.3390/nu14163401. PMID: 36014904; PMCID: PMC9413298.Dasari S., Ali S.M., Zheng G., Chen A., Dontaraju V.S., Bosland M.C., Kajdacsy-balla A., Gnanasekar M. Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget. 2017;8:57782–57799. DOI: 10.18632/oncotarget.17997.Dasari S., Ali S.M., Zheng G., Chen A., Dontaraju V.S., Bosland M.C., Kajdacsy-balla A., Gnanasekar M. Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget. 2017;8:57782–57799. DOI: 10.18632/oncotarget.17997.Simes D.C. et al. Vitamin K as a diet supplement with impact in human health: current evidence in age-related diseases // Nutrients. — 2020. — Т. 12. — №. 1. — С. 138.Simes D.C. et al. Vitamin K as a diet supplement with impact in human health: current evidence in age-related diseases // Nutrients. — 2020. — Т. 12. — №. 1. — С. 138.Chen L., Hsiao F., Shen L., Wu F.L., Tsay W. Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study. PLoS ONE 2016, 27, e0158407.Chen L., Hsiao F., Shen L., Wu F.L., Tsay W. Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study. PLoS ONE 2016, 27, e0158407.Vroonhof K., Van Rijn H.J.M., Van Hattum J. Vitamin K deficiency and bleeding after long-term use of cholestyramine. Neth. J. Med. 2003, 61, 19–21. MacWalter, R.; Fraser, H.; Armstrong, K. Orlistat Enhances Warfarin Effect. Ann. Pharmacother. 2003, 37, 510–512.Vroonhof K., Van Rijn H.J.M., Van Hattum J. Vitamin K deficiency and bleeding after long-term use of cholestyramine. Neth. J. Med. 2003, 61, 19–21. MacWalter, R.; Fraser, H.; Armstrong, K. Orlistat Enhances Warfarin Effect. Ann. Pharmacother. 2003, 37, 510–512.Ishizu T., Torii S., Taguchi M. Association between serum uncarboxylated osteocalcin levels and nutritional intake in Japanese female athletes. Phys Act Nutr. 2022 Sep;26(3):1–5. DOI: 10.20463/pan.2022.0012. Epub 2022 Sep 30. PMID: 36353824; PMCID: PMC9663258.Ishizu T., Torii S., Taguchi M. Association between serum uncarboxylated osteocalcin levels and nutritional intake in Japanese female athletes. Phys Act Nutr. 2022 Sep;26(3):1–5. DOI: 10.20463/pan.2022.0012. Epub 2022 Sep 30. PMID: 36353824; PMCID: PMC9663258.Crintea A., Dutu A.G., Sovrea A., Constantin A.M., Samasca G., Masalar A.L., Ifju B., Linga E., Neamti L., Tranca R.A., Fekete Z., Silaghi C.N., Craciun A.M. Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. Nanomaterials (Basel). 2022 Apr 17;12(8):1376. DOI: 10.3390/nano12081376. PMID: 35458084; PMCID: PMC9024560.Crintea A., Dutu A.G., Sovrea A., Constantin A.M., Samasca G., Masalar A.L., Ifju B., Linga E., Neamti L., Tranca R.A., Fekete Z., Silaghi C.N., Craciun A.M. Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. Nanomaterials (Basel). 2022 Apr 17;12(8):1376. DOI: 10.3390/nano12081376. PMID: 35458084; PMCID: PMC9024560.Zhou M., Han S., Zhang W., Wu D. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review. J Bone Miner Metab. 2022 Sep;40(5):763–772. DOI: 10.1007/s00774022-01342-6. Epub 2022 Jun 16. PMID: 35711002.Zhou M., Han S., Zhang W., Wu D. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review. J Bone Miner Metab. 2022 Sep;40(5):763–772. DOI: 10.1007/s00774022-01342-6. Epub 2022 Jun 16. PMID: 35711002.Simes D.C., Viegas C.S.B., Araújo N., Marreiros C. Vitamin K as a Powerful Micronutrient in Aging and Age-Related Diseases: Pros and Cons from Clinical Studies. Int J Mol Sci. 2019 Aug 25;20(17):4150. DOI: 10.3390/ijms20174150. PMID: 31450694; PMCID: PMC6747195.Simes D.C., Viegas C.S.B., Araújo N., Marreiros C. Vitamin K as a Powerful Micronutrient in Aging and Age-Related Diseases: Pros and Cons from Clinical Studies. Int J Mol Sci. 2019 Aug 25;20(17):4150. DOI: 10.3390/ijms20174150. PMID: 31450694; PMCID: PMC6747195.Rejnmark L., Vestergaard P., Charles P., Hermann A.P., Brot C., Eiken P., Mosekilde L. No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int. 2006;17(8):1122–32. DOI: 10.1007/s00198-005-0044-3. Epub 2006 May 9. PMID: 16683180.Rejnmark L., Vestergaard P., Charles P., Hermann A.P., Brot C., Eiken P., Mosekilde L. No effect of vitamin K1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int. 2006;17(8):1122–32. DOI: 10.1007/s00198-005-0044-3. Epub 2006 May 9. PMID: 16683180.EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Turck D., Bresson J.L., Burlingame B., Dean T., Fairweather-Tait S., Heinonen M., Hirsch-Ernst K.I., Mangelsdorf I., McArdle H.J., Naska A., Nowicka G., Pentieva K., Sanz Y., Siani A., Sjödin A., Stern M., Tomé D., Van Loveren H., Vinceti M., Willatts P., Lamberg-Allardt C., Przyrembel H., Tetens I., Dumas C., Fabiani L., Ioannidou S., Neuhäuser-Berthold M. Dietary reference values for vitamin K. EFSA J. 2017 May 22;15(5):e04780. DOI: 10.2903/j.efsa.2017.4780. PMID: 32625486; PMCID: PMC7010012.EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Turck D., Bresson J.L., Burlingame B., Dean T., Fairweather-Tait S., Heinonen M., Hirsch-Ernst K.I., Mangelsdorf I., McArdle H.J., Naska A., Nowicka G., Pentieva K., Sanz Y., Siani A., Sjödin A., Stern M., Tomé D., Van Loveren H., Vinceti M., Willatts P., Lamberg-Allardt C., Przyrembel H., Tetens I., Dumas C., Fabiani L., Ioannidou S., Neuhäuser-Berthold M. Dietary reference values for vitamin K. EFSA J. 2017 May 22;15(5):e04780. DOI: 10.2903/j.efsa.2017.4780. PMID: 32625486; PMCID: PMC7010012.Apalset E.M., Gjesdal C.G., Eide G.E., Tell G.S. Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. Bone. 2011;49:990–995. DOI: 10.1016/j.bone.2011.07.035Apalset E.M., Gjesdal C.G., Eide G.E., Tell G.S. Intake of vitamin K1 and K2 and risk of hip fractures: The Hordaland Health Study. Bone. 2011;49:990–995. DOI: 10.1016/j.bone.2011.07.035Shiraki M., Shiraki Y., Aoki C., Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J. Bone Miner. Res. 2000;15:515–521. DOI: 10.1359/jbmr.2000.15.3.515.Shiraki M., Shiraki Y., Aoki C., Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J. Bone Miner. Res. 2000;15:515–521. DOI: 10.1359/jbmr.2000.15.3.515.Avenell A., Grey A., Gamble G.D., Bolland M.J. Concerns About the Integrity of the Yamaguchi Osteoporosis Prevention Study (YOPS) Report, Am J Med. 2004;117:549–555. Am J Med. 2020 Jun;133(6):e311–e314. DOI: 10.1016/j.amjmed.2020.02.007. PMID: 32532372.Avenell A., Grey A., Gamble G.D., Bolland M.J. Concerns About the Integrity of the Yamaguchi Osteoporosis Prevention Study (YOPS) Report, Am J Med. 2004;117:549–555. Am J Med. 2020 Jun;133(6):e311–e314. DOI: 10.1016/j.amjmed.2020.02.007. PMID: 32532372.Inoue T., Fujita T., Kishimoto H., Makino T., Nakamura T., Nakamura T., Sato T., Yamazaki K. Randomized controlled study on the prevention of osteoporotic fractures (OF Study): A phase IV clinical study of 15-mg menatetrenone capsules. J. Bone Miner. Metab. 2009;27:66–75. DOI: 10.1007/s00774-008-0008-8.Inoue T., Fujita T., Kishimoto H., Makino T., Nakamura T., Nakamura T., Sato T., Yamazaki K. Randomized controlled study on the prevention of osteoporotic fractures (OF Study): A phase IV clinical study of 15-mg menatetrenone capsules. J. Bone Miner. Metab. 2009;27:66–75. DOI: 10.1007/s00774-008-0008-8.Huang Z.B., Wan S.L., Lu Y.J., Ning L., Liu C., Fan S.W. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: A meta-analysis of randomized controlled trials. Osteoporos. Int. 2015;26:1175– 1186. DOI: 10.1007/s00198-014-2989-6.Huang Z.B., Wan S.L., Lu Y.J., Ning L., Liu C., Fan S.W. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: A meta-analysis of randomized controlled trials. Osteoporos. Int. 2015;26:1175– 1186. DOI: 10.1007/s00198-014-2989-6.Mott A., Bradley T., Wright K., Cockayne E.S., Shearer M.J., Adamson J., Lanham-New S.A., Torgerson D.J. Effect of vitamin K on bone mineral density and fractures in adults: An updated systematic review and meta-analysis of randomised controlled trials. Osteoporos. Int. 2019;30:1543–1559. DOI: 10.1007/s00198-019-04949-0.Mott A., Bradley T., Wright K., Cockayne E.S., Shearer M.J., Adamson J., Lanham-New S.A., Torgerson D.J. Effect of vitamin K on bone mineral density and fractures in adults: An updated systematic review and meta-analysis of randomised controlled trials. Osteoporos. Int. 2019;30:1543–1559. DOI: 10.1007/s00198-019-04949-0.Palermo A., Tuccinardi D., D’Onofrio L., Watanabe M., Maggi D., Maurizi A.R., Greto V., Buzzetti R., Napoli N., Pozzilli P., et al. Vitamin K and osteoporosis: Myth or reality? Metabolism. 2017;70:57–71. DOI: 10.1016/j.metabol.2017.01.032.Palermo A., Tuccinardi D., D’Onofrio L., Watanabe M., Maggi D., Maurizi A.R., Greto V., Buzzetti R., Napoli N., Pozzilli P., et al. Vitamin K and osteoporosis: Myth or reality? Metabolism. 2017;70:57–71. DOI: 10.1016/j.metabol.2017.01.032.Tanaka S., Miyazaki T., Uemura Y., Kuroda T., Miyakawa N., Nakamura T., Fukunaga M., Ohashi Y., Ohta H., Mori S., et al. Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03. J. Bone Miner. Metab. 2017;35:385–395. DOI: 10.1007/s00774-016-0768-5.Tanaka S., Miyazaki T., Uemura Y., Kuroda T., Miyakawa N., Nakamura T., Fukunaga M., Ohashi Y., Ohta H., Mori S., et al. Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03. J. Bone Miner. Metab. 2017;35:385–395. DOI: 10.1007/s00774-016-0768-5.Giri T.K., Newton D., Chaudhary O., Deych E., Napoli N., Villareal R., Diemer K., Milligan P.E., Gage F.B. Maximal doseresponse of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis. Int. J. Vitam. Nutr. Res. 2019:1–7. DOI: 10.1024/0300-9831/a000554.Giri T.K., Newton D., Chaudhary O., Deych E., Napoli N., Villareal R., Diemer K., Milligan P.E., Gage F.B. Maximal doseresponse of vitamin-K2 (menaquinone-4) on undercarboxylated osteocalcin in women with osteoporosis. Int. J. Vitam. Nutr. Res. 2019:1–7. DOI: 10.1024/0300-9831/a000554.Neogi T., Booth S.L., Zhang Y.Q., Jacques P.F., Terkeltaub R., Aliabadi P., Felson D.T. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006;54:1255– 1261. DOI: 10.1002/art.21735.Neogi T., Booth S.L., Zhang Y.Q., Jacques P.F., Terkeltaub R., Aliabadi P., Felson D.T. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006;54:1255– 1261. DOI: 10.1002/art.21735.Oka H., Akune T., Muraki S., En-yo Y., Yoshida M., Saika A., Sasaki S., Nakamura K., Kawaguchi H., Yoshimura N. Association of low dietary vitamin K intake with radiographic knee osteoarthritis in the Japanese elderly population: Dietary survey in a populationbased cohort of the ROAD study. J. Orthop. Sci. 2009;14:687–692. DOI: 10.1007/s00776-009-1395-y.Oka H., Akune T., Muraki S., En-yo Y., Yoshida M., Saika A., Sasaki S., Nakamura K., Kawaguchi H., Yoshimura N. Association of low dietary vitamin K intake with radiographic knee osteoarthritis in the Japanese elderly population: Dietary survey in a populationbased cohort of the ROAD study. J. Orthop. Sci. 2009;14:687–692. DOI: 10.1007/s00776-009-1395-y.Misra D., Booth S.L., Tolstykh I., Felson D.T., Nevitt M.C., Lewis C.E., Torner J., Neogi T. Vitamin K deficiency is associated with incident knee osteoarthritis. Am. J. Med. 2013;126:243–248. DOI: 10.1016/j.amjmed.2012.10.011.Misra D., Booth S.L., Tolstykh I., Felson D.T., Nevitt M.C., Lewis C.E., Torner J., Neogi T. Vitamin K deficiency is associated with incident knee osteoarthritis. Am. J. Med. 2013;126:243–248. DOI: 10.1016/j.amjmed.2012.10.011.Shea M.K., Kritchevsky S.B., Hsu F.C., Nevitt M., Booth S.L., Kwoh C.K., McAlindon T.E., Vermeer C., Drummen N., Harris T.B., et al. The association between vitamin K status and knee osteoarthritis features in older adults: The health, aging and body composition study. Osteoarthr. Cartil. 2015;23:370–378. DOI: 10.1016/j.joca.2014.12.008.Shea M.K., Kritchevsky S.B., Hsu F.C., Nevitt M., Booth S.L., Kwoh C.K., McAlindon T.E., Vermeer C., Drummen N., Harris T.B., et al. The association between vitamin K status and knee osteoarthritis features in older adults: The health, aging and body composition study. Osteoarthr. Cartil. 2015;23:370–378. DOI: 10.1016/j.joca.2014.12.008.Chin K.Y., Pang K.L., Wong S.K., Chew D.C.H., Qodriyah H.M.S. Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review. Drugs Aging. 2022 Jul;39(7):487–504. DOI: 10.1007/s40266-022-00945-y. Epub 2022 May 30. PMID: 35635615.Chin K.Y., Pang K.L., Wong S.K., Chew D.C.H., Qodriyah H.M.S. Relationship Amongst Vitamin K Status, Vitamin K Antagonist Use and Osteoarthritis: A Review. Drugs Aging. 2022 Jul;39(7):487–504. DOI: 10.1007/s40266-022-00945-y. Epub 2022 May 30. PMID: 35635615.Wallin R., Schurgers L.J., Loeser R.F. Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: A fetuin-MGP protein complex is assembled in vesicles shed from normal but not from osteoarthritic chondrocytes. Osteoarthr. Cartil. 2010;18:1096–1103. DOI: 10.1016/j.joca.2010.05.013.Wallin R., Schurgers L.J., Loeser R.F. Biosynthesis of the vitamin K-dependent matrix Gla protein (MGP) in chondrocytes: A fetuin-MGP protein complex is assembled in vesicles shed from normal but not from osteoarthritic chondrocytes. Osteoarthr. Cartil. 2010;18:1096–1103. DOI: 10.1016/j.joca.2010.05.013.Silaghi C., Fodor D., Cristea V., Crãciun A.M. Synovial and serum levels of uncarboxylated matrix Gla-protein (ucMGP) in patients with arthritis. Clin. Chem. Lab. Med. 2012;50:125–128. DOI: 10.1515/cclm.2011.713.Silaghi C., Fodor D., Cristea V., Crãciun A.M. Synovial and serum levels of uncarboxylated matrix Gla-protein (ucMGP) in patients with arthritis. Clin. Chem. Lab. Med. 2012;50:125–128. DOI: 10.1515/cclm.2011.713.Shea M.K., Kritchevsky S.B., Hsu F.C., Nevitt M., Booth S.L., Kwoh C.K., McAlindon T.E., Vermeer C., Drummen N., Harris T.B., et al. The association between vitamin K status and knee osteoarthritis features in older adults: The health, aging and body composition study. Osteoarthr. Cartil. 2015;23:370–378. DOI: 10.1016/j.joca.2014.12.008Shea M.K., Kritchevsky S.B., Hsu F.C., Nevitt M., Booth S.L., Kwoh C.K., McAlindon T.E., Vermeer C., Drummen N., Harris T.B., et al. The association between vitamin K status and knee osteoarthritis features in older adults: The health, aging and body composition study. Osteoarthr. Cartil. 2015;23:370–378. DOI: 10.1016/j.joca.2014.12.008Neogi T., Felson D.T., Sarno R., Booth S.L. Vitamin K in hand osteoarthritis: Results from a randomised clinical trial. Ann. Rheum Dis. 2008;67:1570–1573. DOI: 10.1136/ard.2008.094771.Neogi T., Felson D.T., Sarno R., Booth S.L. Vitamin K in hand osteoarthritis: Results from a randomised clinical trial. Ann. Rheum Dis. 2008;67:1570–1573. DOI: 10.1136/ard.2008.094771.Cavaco S., Viegas C.S., Rafael M.S., Ramos A., Magalhães J., Blanco F.J., Vermeer C., Simes D.C. Gla-rich protein is involved in the cross-talk between calcification and inflammation in osteoarthritis. Cell. Mol. Life Sci. 2016;73:1051–1065. DOI: 10.1007/s00018-015-2033-9.Cavaco S., Viegas C.S., Rafael M.S., Ramos A., Magalhães J., Blanco F.J., Vermeer C., Simes D.C. Gla-rich protein is involved in the cross-talk between calcification and inflammation in osteoarthritis. Cell. Mol. Life Sci. 2016;73:1051–1065. DOI: 10.1007/s00018-015-2033-9.Greene M.A., Loeser R.F. Aging-related inflammation in osteoarthritis. Osteoarthr. Cartil. 2015;23:1966–1971. DOI: 10.1016/j.joca.2015.01.008.Greene M.A., Loeser R.F. Aging-related inflammation in osteoarthritis. Osteoarthr. Cartil. 2015;23:1966–1971. DOI: 10.1016/j.joca.2015.01.008.Mangge H., Prueller F., Dawczynski C., Curcic P., Sloup Z., Holter M., Herrmann M., Meinitzer A. Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants (Basel). 2022 Jun 24;11(7):1235. DOI: 10.3390/antiox11071235. PMID: 35883726; PMCID: PMC9312339.Mangge H., Prueller F., Dawczynski C., Curcic P., Sloup Z., Holter M., Herrmann M., Meinitzer A. Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants (Basel). 2022 Jun 24;11(7):1235. DOI: 10.3390/antiox11071235. PMID: 35883726; PMCID: PMC9312339.Gough M., Singh D.K., Singh B., Kaushal D., Mehra S. System-wide identification of myeloid markers of TB disease and HIV-induced reactivation in the macaque model of Mtb infection and Mtb/SIV co-infection. Front Immunol. 2022 Oct 5;13:777733. DOI: 10.3389/fimmu.2022.777733. PMID: 36275677; PMCID: PMC9583676.Gough M., Singh D.K., Singh B., Kaushal D., Mehra S. System-wide identification of myeloid markers of TB disease and HIV-induced reactivation in the macaque model of Mtb infection and Mtb/SIV co-infection. Front Immunol. 2022 Oct 5;13:777733. DOI: 10.3389/fimmu.2022.777733. PMID: 36275677; PMCID: PMC9583676.Jung S., Choi B.H., Joo N.S. Serum Homocysteine and Vascular Calcification: Advances in Mechanisms, Related Diseases, and Nutrition. Korean J Fam Med. 2022 Sep;43(5):277–289. DOI: 10.4082/kjfm.21.0227. Epub 2022 Sep 20. PMID: 36168899; PMCID: PMC9532189.Jung S., Choi B.H., Joo N.S. Serum Homocysteine and Vascular Calcification: Advances in Mechanisms, Related Diseases, and Nutrition. Korean J Fam Med. 2022 Sep;43(5):277–289. DOI: 10.4082/kjfm.21.0227. Epub 2022 Sep 20. PMID: 36168899; PMCID: PMC9532189.Beulens J.W., Bots M.L., Atsma F., Bartelink M.L., Prokop M., Geleijnse J.M., Witteman J.C., Grobbee D.E., van der Schouw Y.T. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009:489–493. DOI: 10.1016/j.atherosclerosis.2008.07.010.Beulens J.W., Bots M.L., Atsma F., Bartelink M.L., Prokop M., Geleijnse J.M., Witteman J.C., Grobbee D.E., van der Schouw Y.T. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009:489–493. DOI: 10.1016/j.atherosclerosis.2008.07.010.Geleijnse J.M., Vermeer C., Grobbee D.E., Schurgers L.J., Knapen M.H., van der Meer I.M., Hofman A., Witteman J.C. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J. Nutr. 2004;134:3100–3105. DOI: 10.1093/jn/134.11.3100.Geleijnse J.M., Vermeer C., Grobbee D.E., Schurgers L.J., Knapen M.H., van der Meer I.M., Hofman A., Witteman J.C. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: The Rotterdam Study. J. Nutr. 2004;134:3100–3105. DOI: 10.1093/jn/134.11.3100.Gast G.C., de Roos N.M., Sluijs I., Bots M.L., Beulens J.W., Geleijnse J.M., Witteman J.C., Grobbee D.E., Peeters P.H., van der Schouw Y.T. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 2009;19:504–510. DOI: 10.1016/j.numecd.2008.10.004.Gast G.C., de Roos N.M., Sluijs I., Bots M.L., Beulens J.W., Geleijnse J.M., Witteman J.C., Grobbee D.E., Peeters P.H., van der Schouw Y.T. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 2009;19:504–510. DOI: 10.1016/j.numecd.2008.10.004.Lai Y., Masatoshi H., Ma Y., Guo Y., Zhang B. Role of Vitamin K in Intestinal Health. Front Immunol. 2022 Jan 5;12:791565. DOI: 10.3389/fimmu.2021.791565. PMID: 35069573; PMCID: PMC8769504.Lai Y., Masatoshi H., Ma Y., Guo Y., Zhang B. Role of Vitamin K in Intestinal Health. Front Immunol. 2022 Jan 5;12:791565. DOI: 10.3389/fimmu.2021.791565. PMID: 35069573; PMCID: PMC8769504.Karamzad N., Faraji E., Adeli S., Sullman M.J.M., Pourghassem Gargari B. The effect of menaquinone-7 supplementation on dp-ucMGP, PIVKAII, inflammatory markers, and body composition in type 2 diabetes patients: a randomized clinical trial. Nutr Diabetes. 2022 Apr 1;12(1):15. DOI: 10.1038/s41387-02200192-5. PMID: 35365594; PMCID: PMC8976086.Karamzad N., Faraji E., Adeli S., Sullman M.J.M., Pourghassem Gargari B. The effect of menaquinone-7 supplementation on dp-ucMGP, PIVKAII, inflammatory markers, and body composition in type 2 diabetes patients: a randomized clinical trial. Nutr Diabetes. 2022 Apr 1;12(1):15. DOI: 10.1038/s41387-02200192-5. PMID: 35365594; PMCID: PMC8976086.van Ballegooijen A.J., Beulens J.W. The role of Vitamin K status in cardiovascular health: Evidence from observational and clinical studies. Curr. Nutr. Rep. 2017;6:197–205. DOI: 10.1007/s13668-017-0208-8.van Ballegooijen A.J., Beulens J.W. The role of Vitamin K status in cardiovascular health: Evidence from observational and clinical studies. Curr. Nutr. Rep. 2017;6:197–205. DOI: 10.1007/s13668-017-0208-8.Barrett H., O’Keeffe M., Kavanagh E., Walsh M., O’Connor E.M. Is matrix Gla protein associated with vascular calcification? A systematic review. Nutrients. 2018;10:415. DOI: 10.3390/nu10040415.Barrett H., O’Keeffe M., Kavanagh E., Walsh M., O’Connor E.M. Is matrix Gla protein associated with vascular calcification? A systematic review. Nutrients. 2018;10:415. DOI: 10.3390/nu10040415.Puzantian H., Akers S.R., Oldland G., Javaid K., Miller R., Ge Y., Ansari B., Lee J., Suri A., Hasmath Z., et al. Circulating dephospho-uncarboxylated matrix Gla-protein is associated with kidney dysfunction and arterial stiffness. Am. J. Hypertens. 2018;31:988– 994. DOI: 10.1093/ajh/hpy079.Puzantian H., Akers S.R., Oldland G., Javaid K., Miller R., Ge Y., Ansari B., Lee J., Suri A., Hasmath Z., et al. Circulating dephospho-uncarboxylated matrix Gla-protein is associated with kidney dysfunction and arterial stiffness. Am. J. Hypertens. 2018;31:988– 994. DOI: 10.1093/ajh/hpy079.Sardana M., Vasim I., Varakantam S., Kewan U., Tariq A., Koppula M.R., Syed A.A., Beraun M., Drummen N.E., Vermeer C., Akers S.R., Chirinos J.A. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus. Am J Hypertens. 2017 Feb;30(2):196–201. DOI: 10.1093/ajh/hpw146. Epub 2016 Dec 7. PMID: 27927630.Sardana M., Vasim I., Varakantam S., Kewan U., Tariq A., Koppula M.R., Syed A.A., Beraun M., Drummen N.E., Vermeer C., Akers S.R., Chirinos J.A. Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus. Am J Hypertens. 2017 Feb;30(2):196–201. DOI: 10.1093/ajh/hpw146. Epub 2016 Dec 7. PMID: 27927630.Aoun M., Makki M., Azar H., Matta H., Chelala D.N. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial. BMC Nephrol. 2017 Jun 7;18(1):191. DOI: 10.1186/s12882-017-0609-3. PMID: 28592319; PMCID: PMC5463325.Aoun M., Makki M., Azar H., Matta H., Chelala D.N. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial. BMC Nephrol. 2017 Jun 7;18(1):191. DOI: 10.1186/s12882-017-0609-3. PMID: 28592319; PMCID: PMC5463325.Seidlerová J., Wohlfahrt P., Filipovský J., Vaněk J., Cífková R., Windrichová J., Topolčan O., Knapen M.H., Drummen N.E., Vermeer C., et al. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. J. Hum. Hypertens. 2015;30:418–423. DOI: 10.1038/jhh.2015.55.Seidlerová J., Wohlfahrt P., Filipovský J., Vaněk J., Cífková R., Windrichová J., Topolčan O., Knapen M.H., Drummen N.E., Vermeer C., et al. Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population. J. Hum. Hypertens. 2015;30:418–423. DOI: 10.1038/jhh.2015.55.Pivin E., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Liu Y.P., Drummen N.E., Knapen M.H., Pechere-Bertschi A., et al. Inactive Matrix Gla-Protein Is associated with arterial stiffness in an adult population-based study. Hypertension. 2015;66:85–92. DOI: 10.1161/HYPERTENSIONAHA.115.05177.Pivin E., Ponte B., Pruijm M., Ackermann D., Guessous I., Ehret G., Liu Y.P., Drummen N.E., Knapen M.H., Pechere-Bertschi A., et al. Inactive Matrix Gla-Protein Is associated with arterial stiffness in an adult population-based study. Hypertension. 2015;66:85–92. DOI: 10.1161/HYPERTENSIONAHA.115.05177.van den Heuvel E.M., van Schoor N.M., Lips P., Magdeleyns E.P., Deeg D.H., Vermeer C., den Heijer M. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas. 2014;77:137– 141. DOI: 10.1016/j.maturitas.2013.10.008.van den Heuvel E.M., van Schoor N.M., Lips P., Magdeleyns E.P., Deeg D.H., Vermeer C., den Heijer M. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease. Maturitas. 2014;77:137– 141. DOI: 10.1016/j.maturitas.2013.10.008.Hariri E., Kassis N., Iskandar J.P., Schurgers L.J., Saad A., Abdelfattah O., Bansal A., Isogai T., Harb S.C., Kapadia S. Vitamin K2-a neglected player in cardiovascular health: a narrative review. Open Heart. 2021 Nov;8(2):e001715. DOI: 10.1136/openhrt-2021-001715. PMID: 34785587; PMCID: PMC8596038.Hariri E., Kassis N., Iskandar J.P., Schurgers L.J., Saad A., Abdelfattah O., Bansal A., Isogai T., Harb S.C., Kapadia S. Vitamin K2-a neglected player in cardiovascular health: a narrative review. Open Heart. 2021 Nov;8(2):e001715. DOI: 10.1136/openhrt-2021-001715. PMID: 34785587; PMCID: PMC8596038.Houston D.K., Tooze J.A., Neiberg R.H., Hausman D.B., Johnson M.A., Cauley J.A., Bauer D.C., Cawthon P.M., Shea M.K., Schwartz G.G., et al. 25-Hydroxyvitamin D status and change in physical performance and strength in older adults: The Health, Aging, and Body Composition Study. Am. J. Epidemiol. 2012;176:1025–1034. DOI: 10.1093/aje/kws147.Houston D.K., Tooze J.A., Neiberg R.H., Hausman D.B., Johnson M.A., Cauley J.A., Bauer D.C., Cawthon P.M., Shea M.K., Schwartz G.G., et al. 25-Hydroxyvitamin D status and change in physical performance and strength in older adults: The Health, Aging, and Body Composition Study. Am. J. Epidemiol. 2012;176:1025–1034. DOI: 10.1093/aje/kws147.Shea M.K., Booth S.L., Weiner D.E., Brinkley T.E., Kanaya A.M., Murphy R.A., Simonsick E.M., Wassel C.L., Vermeer C., Kritchevsky S.B. Circulating vitamin K is inversely associated with incident cardiovascular disease risk among those treated for hypertension in the Health, Aging, and Body Composition Study (Health ABC) J. Nutr. 2017;147:888–895. DOI: 10.3945/jn.117.249375.Shea M.K., Booth S.L., Weiner D.E., Brinkley T.E., Kanaya A.M., Murphy R.A., Simonsick E.M., Wassel C.L., Vermeer C., Kritchevsky S.B. Circulating vitamin K is inversely associated with incident cardiovascular disease risk among those treated for hypertension in the Health, Aging, and Body Composition Study (Health ABC) J. Nutr. 2017;147:888–895. DOI: 10.3945/jn.117.249375.Zhang S., Guo L., Bu C. Vitamin K status and cardiovascular events or mortality: A meta-analysis. Eur. J. Prev. Cardiol. 2018;26:549–553. DOI: 10.1177/2047487318808066.Zhang S., Guo L., Bu C. Vitamin K status and cardiovascular events or mortality: A meta-analysis. Eur. J. Prev. Cardiol. 2018;26:549–553. DOI: 10.1177/2047487318808066.Shea M.K., O’Donnell C.J., Vermeer C., Magdeleyns E.P., Crosier M.D., Gundberg C.M., Ordovas J.M., Kritchevsky S.B., Booth S.L. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J. Nutr. 2011;141:1529–1534. DOI: 10.3945/jn.111.139634.Shea M.K., O’Donnell C.J., Vermeer C., Magdeleyns E.P., Crosier M.D., Gundberg C.M., Ordovas J.M., Kritchevsky S.B., Booth S.L. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J. Nutr. 2011;141:1529–1534. DOI: 10.3945/jn.111.139634.Dalmeijer G.W., van der Schouw Y.T., Magdeleyns E.J., Vermeer C., Verschuren W.M.M., Boer J.M., Beulens J.W.J. Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and stroke. J. Thromb. Haemost. 2014;12:1028–1034. DOI: 10.1111/jth.12609.Dalmeijer G.W., van der Schouw Y.T., Magdeleyns E.J., Vermeer C., Verschuren W.M.M., Boer J.M., Beulens J.W.J. Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and stroke. J. Thromb. Haemost. 2014;12:1028–1034. DOI: 10.1111/jth.12609.Knapen M., Braam L., Drummen N., Bekers O., Hoeks A.G., Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb. Haemost. 2015;113:1135–1144. DOI: 10.1160/TH14-08-0675.Knapen M., Braam L., Drummen N., Bekers O., Hoeks A.G., Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. Thromb. Haemost. 2015;113:1135–1144. DOI: 10.1160/TH14-08-0675.Holden R.M., Morton A.R., Garland J.S., Pavlov A., Day A.G., Booth S.L. Vitamins K and D status in stages 3–5 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010;5:590–597. DOI: 10.2215/CJN.06420909.Holden R.M., Morton A.R., Garland J.S., Pavlov A., Day A.G., Booth S.L. Vitamins K and D status in stages 3–5 chronic kidney disease. Clin. J. Am. Soc. Nephrol. 2010;5:590–597. DOI: 10.2215/CJN.06420909.Caluwé R., Vandecasteele S., Van Vlem B., Vermeer C., De Vriese A.S. Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol. Dial. Transplant. 2014;29:1385–1390. DOI: 10.1093/ndt/gft464.Caluwé R., Vandecasteele S., Van Vlem B., Vermeer C., De Vriese A.S. Vitamin K2 supplementation in haemodialysis patients: A randomized dose-finding study. Nephrol. Dial. Transplant. 2014;29:1385–1390. DOI: 10.1093/ndt/gft464.Aoun M., Makki M., Azar H., Matta H., Chelala D.N. High dephosphorylated-uncarboxylated MGP in hemodialysis patients: Risk factors and response to vitamin K2, a pre-post intervention clinical trial. BMC Nephrol. 2017;18:191. DOI: 10.1186/s12882-017-0609-3.Aoun M., Makki M., Azar H., Matta H., Chelala D.N. High dephosphorylated-uncarboxylated MGP in hemodialysis patients: Risk factors and response to vitamin K2, a pre-post intervention clinical trial. BMC Nephrol. 2017;18:191. DOI: 10.1186/s12882-017-0609-3.Silva A.P., Viegas C.S., Simes D.C., Mendes F., Tavares N., Rato F., Santos N., Neves P.L. Gla-Rich Protein as a novel marker for calcifications in diabetic patients with CKD. Nephrol. Dial. Transpl. 2018;33:i493. DOI: 10.1093/ndt/gfy104.SP430.Silva A.P., Viegas C.S., Simes D.C., Mendes F., Tavares N., Rato F., Santos N., Neves P.L. Gla-Rich Protein as a novel marker for calcifications in diabetic patients with CKD. Nephrol. Dial. Transpl. 2018;33:i493. DOI: 10.1093/ndt/gfy104.SP430.Violi F. et al. Interaction between dietary vitamin K intake and anticoagulation by vitamin K antagonists: is it really true?: a systematic review //Medicine. — 2016. — Т. 95. — № 10.Violi F. et al. Interaction between dietary vitamin K intake and anticoagulation by vitamin K antagonists: is it really true?: a systematic review //Medicine. — 2016. — Т. 95. — № 10.Dashti H.S., Shea M.K., Smith C.E., et al. Meta-analysis of genomewide association studies for circulating phylloquinone concentrations. Am J Clin Nutr. 2014;100:1462–1469.Dashti H.S., Shea M.K., Smith C.E., et al. Meta-analysis of genomewide association studies for circulating phylloquinone concentrations. Am J Clin Nutr. 2014;100:1462–1469.Pignatelli P., Pastori D., Vicario T., et al. Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. Europace. 2015;17.Pignatelli P., Pastori D., Vicario T., et al. Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking vitamin K antagonists. Europace. 2015;17.National Institutes of Health. Dietary Supplement Label Database. 2014.National Institutes of Health. Dietary Supplement Label Database. 2014.Schurgers L.J., Teunissen K.J., Hamulyak K., Knapen M.H., Vik H., Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007;109:3279–83.Schurgers L.J., Teunissen K.J., Hamulyak K., Knapen M.H., Vik H., Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007;109:3279–83.

The authors declare that there are no conflicts of interest present.